Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Maersk Notification

4 May 2017 14:55

RNS Number : 2325E
Quadrise Fuels International PLC
04 May 2017
 

4 May 2017

 

Quadrise Fuels International plc

("Quadrise", "QFI" or the "Company")

 

Maersk Notification

 

Quadrise Fuels International plc (AIM:QFI), the emerging supplier of MSAR® emulsion technology and fuel, enabling a low-cost alternative to heavy fuel oil (one of the world's largest fuels markets, comprising over 450 million tonnes per annum) in the global shipping, refining and power generation markets, announces that the Company and supply partner CEPSA have been formally notified by Maersk Line A/S ("Maersk") of its intention to let the Operational Trial Agreement between the parties expire once the MSAR® fuel currently on-board the test vessel has been consumed (the "Notification").

 

Further to the Company's announcement of 7 April 2017, Maersk has now formally notified the Company of its intention, in achieving compliance with the International Maritime Organisation's ("IMO") 2020 sulphur limit environmental legislation, to use only compliant fuel (less than 0.5% sulphur) from 2020 and that the use of MSAR® alongside exhaust gas scrubbers ("Scrubbers") will not be considered as an option for Maersk going forward.

 

Marine MSAR® supplied to date has been higher than 0.5% sulphur and one option in the future is to use such fuel together with exhaust gas scrubbers ("Scrubbers") to achieve IMO 2020 sulphur limit compliance. For operators who choose to use a compliant fuel, a second option would be for QFI to work with refiners or suppliers to produce a compliant (less than 0.5% sulphur) Marine MSAR®, but this would be dependent on availability of low-sulphur residual streams and further work is being carried out to assess the viability of this solution.

 

As recently reaffirmed by Maersk, the MSAR® operational trial has been successful to date and this should be further confirmed by the interim inspection report and Interim LONO from Wärtsilä. Following receipt of the Notification the Company is continuing to work with Maersk to progress the release of the interim inspection report and an Interim LONO for MSAR® use and to clarify Maersk's previously confirmed intention to work collaboratively with QFI to use the aforementioned to progress the commercialisation of MSAR® to the wider global marine industry.

 

QFI continues to believe that the industry will ultimately move to the use of Scrubbers and high sulphur fuel as the most economic compliance option and that Marine MSAR® will enable operators to obtain additional economic and environmental advantages over the use of heavy fuel oil. As noted in the announcement of 7th April 2017, the commercialisation of Marine MSAR® will now be focused on other operators and we are actively working on this, though this will have a longer lead-time than the originally envisioned plans with Maersk.

 

Mike Kirk, Executive Chairman, said:

 

"As we have previously highlighted, whilst Maersk's decision is disappointing, we are working hard to ensure that we can gain the benefit from the positive results of the trial to date. We are actively engaged with Maersk to progress the interim inspection report and interim LONO. 

 

The underlying opportunity remains substantial and many in the marine fuel and refining industries see the use of high sulphur fuel and scrubbers as the most economic option for compliance with the 2020 IMO sulphur regulations.

 

It is also important to note that this decision by Maersk is enabling both QFI and Cepsa to further progress plans for the use of the spare MSAR® production capacity for new customers in the marine and power markets."

 

This announcement is inside information for the purposes of Article 7 of EU Regulation 596/2014.

For further information, please refer to the Company's website at www.quadrisefuels.com or contact:

 

Quadrise Fuels International Plc

 

Mike Kirk, Executive Chairman

+44 (0)20 7031 7321

Hemant Thanawala, Finance Director

 

 

 

Nominated Adviser

 

Smith & Williamson Corporate Finance Limited

 

Dr Azhic Basirov

+44 (0)20 7131 4000

Ben Jeynes

Katy Birkin

 

 

 

Broker

 

Peel Hunt LLP

 

Richard Crichton

+44 (0)20 7418 8900

Ross Allister 

 

Chris Burrows 

 

 

Public & Investor Relations

 

FTI Consulting

 

Ben Brewerton

+44 (0)20 3727 1000

Sara Powell

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEADSLESFXEFF
Date   Source Headline
10th Dec 20214:41 pmRNSSecond Price Monitoring Extn
10th Dec 20214:36 pmRNSPrice Monitoring Extension
6th Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 20218:00 amEQSEdison Investment Research Limited: Quadrise Fuels International (QFI): Cleaner fuel, cleaner planet
26th Nov 20213:30 pmRNSResult of AGM
26th Nov 20217:00 amRNSAGM Statement
1st Nov 20215:00 pmRNSPosting of Annual Report and Notice of AGM
20th Oct 20215:45 pmRNSMorocco Travel Restrictions
5th Oct 20214:41 pmRNSSecond Price Monitoring Extn
5th Oct 20214:35 pmRNSPrice Monitoring Extension
4th Oct 20217:00 amRNSFinal Results, Directorate Change & Notice of AGM
1st Oct 20217:00 amRNSTotal Voting Rights
24th Sep 20217:00 amRNSNotice of Results and Investor Presentation
23rd Sep 20217:00 amRNSUtah Project Update
20th Sep 20214:36 pmRNSPrice Monitoring Extension
3rd Sep 20212:30 pmRNSIssue of Share Options & Director/PDMR Dealing
2nd Sep 20214:40 pmRNSSecond Price Monitoring Extn
2nd Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSPublication of bioMSAR Test Results
23rd Aug 20217:00 amRNSGreenfield Commercial Trial Agreement Extension
11th Aug 20217:00 amRNSUpdate on bioMSAR™ Testing
4th Aug 20217:00 amRNSUtah Project Update
30th Jul 20219:30 amRNSBlock Admissions
16th Jul 20214:40 pmRNSSecond Price Monitoring Extn
16th Jul 20214:35 pmRNSPrice Monitoring Extension
16th Jul 20211:15 pmRNSDirectorate Change
28th Jun 20217:00 amRNSUpdate on bioMSAR™ and MSAR® projects
17th May 20214:40 pmRNSSecond Price Monitoring Extn
17th May 20214:35 pmRNSPrice Monitoring Extension
4th May 20219:24 amRNSIssue of Equity
22nd Apr 20214:41 pmRNSSecond Price Monitoring Extn
22nd Apr 20214:36 pmRNSPrice Monitoring Extension
16th Apr 20214:40 pmRNSSecond Price Monitoring Extn
16th Apr 20214:35 pmRNSPrice Monitoring Extension
1st Apr 202112:50 pmRNSUpdate re Greenfield Commercial Trial Agreement
29th Mar 20217:00 amRNSInterim Results
25th Mar 20214:40 pmRNSSecond Price Monitoring Extn
25th Mar 20214:35 pmRNSPrice Monitoring Extension
23rd Mar 20217:00 amRNSResults of Open Offer
12th Mar 20217:00 amRNSHolding(s) in Company
10th Mar 20217:00 amRNSHolding(s) in Company
2nd Mar 20217:00 amRNSResults of Placing and Open Offer Launch
1st Mar 20214:41 pmRNSProposed Placing and Open Offer
25th Feb 20214:41 pmRNSSecond Price Monitoring Extn
25th Feb 20214:35 pmRNSPrice Monitoring Extension
23rd Feb 20214:36 pmRNSPrice Monitoring Extension
11th Feb 20214:36 pmRNSPrice Monitoring Extension
11th Feb 20217:00 amRNSFinal Issue of Convertible Securities
4th Feb 20214:41 pmRNSSecond Price Monitoring Extn
4th Feb 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.